- Forbes•6 hours ago
Looking at the earnings posted by Merck & Co. (MRK), I could not help but compare and contrast them with what Sanofi (SNY) said this morning. Like Sanofi had with Lantus, Merck has a mega-blockbuster with Januvia. Just as Lantus was getting long in the tooth and facing patent expiration
- Capital Cube•4 days ago
Click here to see latest analysisETF’s with exposure to Medtronic PlcHere are 5 ETF’s with the largest exposure to MDT-US. Comparing the performance and risk of Medtronic Plc with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility.TickerFund NameMDT-US Exposure (%)1 Year Price […] (Read more...) The post ETF’s with exposure to Medtronic Plc : July 25, 2016 appeared first on CapitalCube.
After hours: 87.800.17 (0.19%) as of 4:50 PM EDT
|Bid||86.68 x 100|
|Ask||87.85 x 100|
|52wk Range||55.54 - 89.27|
|Day's Range||87.07 - 88.18|
|Avg Vol (3m)||5,046,422|
As of 4:03 PM EDT. Market closed.